HCP Inc. (NYSE:HCP) shares rose 1.6% on Tuesday . The company traded as high as $37.97 and last traded at $37.96, with a volume of 1,197,783 shares changing hands. The stock had previously closed at $37.37.

HCP has been the subject of a number of recent analyst reports. Argus reaffirmed a “hold” rating on shares of HCP in a report on Wednesday, June 15th. BMO Capital Markets reaffirmed a “sell” rating on shares of HCP in a report on Tuesday, May 10th. Goldman Sachs Group Inc. raised shares of HCP from a “sell” rating to a “neutral” rating and lifted their price objective for the company from $26.00 to $36.00 in a report on Friday, July 8th. Citigroup Inc. lifted their price objective on shares of HCP from $31.00 to $34.00 and gave the company a “neutral” rating in a report on Monday, May 16th. Finally, Jefferies Group reaffirmed a “neutral” rating on shares of HCP in a report on Wednesday, July 6th. Six equities research analysts have rated the stock with a sell rating, nine have given a hold rating and two have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $33.97.

The firm has a 50-day moving average price of $35.25 and a 200-day moving average price of $33.83. The firm’s market cap is $17.91 billion.

HCP (NYSE:HCP) last announced its quarterly earnings data on Monday, May 9th. The real estate investment trust reported $0.69 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.69. The firm had revenue of $640.80 million for the quarter, compared to analysts’ expectations of $621.93 million. During the same quarter in the previous year, the company posted $0.79 EPS. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. Equities research analysts anticipate that HCP Inc. will post $2.78 EPS for the current fiscal year.

Other institutional investors have recently made changes to their positions in the company. SFE Investment Counsel increased its position in shares of HCP by 3.9% in the fourth quarter. SFE Investment Counsel now owns 231,010 shares of the real estate investment trust’s stock worth $8,834,000 after buying an additional 8,715 shares during the last quarter. Agran Libbie increased its position in shares of HCP by 10,073.6% in the fourth quarter. Agran Libbie now owns 24,472,696 shares of the real estate investment trust’s stock worth $9,358,000 after buying an additional 24,232,146 shares during the last quarter. Private Advisor Group LLC increased its position in shares of HCP by 7.3% in the fourth quarter. Private Advisor Group LLC now owns 145,822 shares of the real estate investment trust’s stock worth $5,576,000 after buying an additional 9,910 shares during the last quarter. Edge Asset Management Inc. increased its position in shares of HCP by 69.8% in the fourth quarter. Edge Asset Management Inc. now owns 268,646 shares of the real estate investment trust’s stock worth $10,273,000 after buying an additional 110,440 shares during the last quarter. Finally, Cornerstone Capital Management Holdings LLC. increased its position in shares of HCP by 9.4% in the fourth quarter. Cornerstone Capital Management Holdings LLC. now owns 458,206 shares of the real estate investment trust’s stock worth $17,522,000 after buying an additional 39,203 shares during the last quarter.

HCP, Inc (HCP) is a self-administered real estate investment trust (REIT). The Company invests in real estate serving the healthcare industry in the United States. Its portfolio consists of investments in various healthcare segments: senior housing, post-acute/skilled nursing, life science, medical office and hospital.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.